Practice guideline for the treatment of patients with delirium

American Journal of Psychiatry

Volumn 156, Issue 5 SUPPL., 1999, Pages 1-20

  Breitbart, W ^a   Franklin, J ^a   Levenson, J ^a   Martini, D R ^a   Wang, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DROPERIDOL; HALOPERIDOL; NEUROLEPTIC AGENT;

ANTICHOLINERGIC EFFECT; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFECT; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; GALACTORRHEA; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; PATIENT CARE; PATIENT CODING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0032951356     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (135)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC, APA, 1994 [F]
2. Lipowski ZJ: Delirium (acute confusional states). JAMA 1987; 258:1789-1792 [F]
3. Lipowski ZJ: Delirium: Acute Confusional States. New York, Oxford University Press, 1990 [G]
4. Ross CA, Peyser CE, Shapiro I: Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 1991; 3:135-147 [F]
5. Stiefel F, Holland J: Delirium in cancer patients. Int Psychogeriatr 1991; 3:333-336 [F]
6. Perry S: Organic mental disorders caused by HIV: update on early diagnosis and treatment. Am J Psychiatry 1990; 147: 696-710 [F]
7. Tune LE: Post-operative delirium. Int Psychogeriatr 1991; 3: 325-332 [F]
8. Massie MJ, Holland J, Glass E: Delirium in terminally ill cancer patients. Am J Psychiatry 1983; 140:1048-1050 [C, G]
9. Rockwood K: The occurrence and duration of symptoms in elderly patients with delirium. J Gerontol 1993; 48:M162-M166 [C]
10. Sirois F: Delirium: 100 cases. Can J Psychiatry 1988; 33:375-378 [D]
11. Koponen H, Stenback U, Mattila E: Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand 1989; 79:579-585 [D]
12. Koizumi J, Shiraishi H, Suzuki T: Duration of delirium shortened by the correction of electrolyte imbalance. Jpn J Psychiatry Neurol 1988; 42:81-88 [D]
13. Rockwood K: Acute confusion in elderly medical patients. J Am Geriatr Soc 1989; 37:150-154 [C]
14. Manos PJ, Wu R: The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Ann Clin Psychiatry 1997; 9:219-226 [C]
15. Levkoff SE, Evans DA, Liptzin B, Cleary PD, Lipsitz LA, Wetle TT, Reilly CH, Pilgrim DM, Schor J, Rowe J: Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 1992; 152:334-340 [C]
16. Fernandez F, Levy JK, Mansell PWA: Management of delirium in terminally ill AIDS patients. Int J Psychiatry Med 1989; 19: 165-172 [C]
17. Inouye S, Horowitz R, Tinetti M, Berkman L: Acute confusional states in the hospitalized elderly: incidence, risk factors and complications (abstract). Clin Res 1989; 37:524A [C]
18. Cole MG, Primeau FJ: Prognosis of delirium in elderly hospital patients. Can Med Assoc J 1993; 149:41-46 [E]
19. Rogers M, Liang M, Daltroy L: Delirium after elective orthopedic surgery: risk factors and natural history. Int J Psychiatry Med 1989; 19:109-121 [C]
20. Gustafson Y, Berggren D, Brannstrom B, Bucht G, Norberg A, Hansson LI, Winblad B: Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc 1988; 36:525-530 [C]
21. Antoon AY, Volpe JJ, Crawford JD: Burn encephalopathy in children. Pediatrics 1972; 50:609-616 [C]
22. Rabins PV, Folstein MF: Delirium and dementia: diagnostic criteria and fatality rates. Br J Psychiatry 1982; 140:149-153 [C]
23. Varsamis J, Zuchowski T, Maini KK: Survival rates and causes of death in geriatric psychiatric patients: a six-year follow-up study. Can Psychiatr Assoc J 1972; 17:17-22 [C]
24. Cameron DJ, Thomas Ri, Mulvihill M, Bronheim H: Delirium: a test of the Diagnostic and Statistical Manual III criteria on medical inpatients. J Am Geriatr Soc 1987; 35:1007-1010 [C]
25. Trzepacz P, Teague G, Lipowski Z: Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 1985; 7:101-106 [G]
26. Weddington WW: The mortality of delirium: an under-appreciated problem? Psychosomatics 1982; 23:1232-1235 [E, F]
27. Inouye SK: The dilemma of delirium: clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994; 97: 278-288 [F]
28. Francis J, Kapoor WN: Delirium in hospitalized elderly. J Gen Intern Med 1990; 5:65-79 [F]
29. Smith MJ, Breitbart WS, Platt MM: A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symptom Manage 1995; 10:35-77 [F]
30. Trzepacz PT: A review of delirium assessment instruments. Gen Hosp Psychiatry 1994; 16:397-405 [F]
31. Levkoff S, Liptzin B, Cleary P, Reilly CH, Evans D: Review of research instruments and techniques used to detect delirium. Int Psychogeriatr 1991; 3:253-271 [F]
32. Vermeersch PE: The Clinical Assessment of Confusion - A. Appl Nurs Res 1990; 3:128-133 [D]
33. Williams MA, Ward SE, Campbell EB: Confusion: testing versus observation. J Gerontol Nurs 1988; 14:25-30 [D]
34. Rutherford L, Sessler C, Levenson JL, Hart R, Best A: Prospective evaluation of delirium and agitation in a medical intensive care unit (abstract). Crit Care Med 1991; 19:S81 [C]
35. Neelon V, Champagne MT, Carlson JR, Funk SG: The NEE-CHAM Confusion Scale: construction, validation, and clinical testing. Nurs Res 1996; 45:324-330 [C]
36. Albert MS, Levkoff SE, Reilly C, Liptzin B, Pilgrim D, Cleary PD, Evans D, Rowe JW: The Delirium Symptom Interview: an interview for the detection of delirium symptoms in hospitalized patients. J Geriatr Psychiatry Neurol 1992; 5:14-21 [C]
37. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI: Clarifying confusion: the confusion assessment method, a new method for the detection of delirium. Ann Intern Med 1990; 113:941-948 [C]
38. Lowy F, Engelsmann F, Lipowski Z: Study of cognitive functioning in a medical population. Compr Psychiatry 1973; 14: 331-338 [C]
39. Anthony JC, LeResche LA, Von Korff MR, Niaz U, Folstein MF: Screening for delirium on a general medical ward: the tachistoscope and a global accessibility rating. Gen Hosp Psychiatry 1985; 7:36-42 [C]
40. Gustafsson I, Lindgren M, Westling B: The OBS Scale: a new rating scale for evaluation of confusional states and other organic brain syndromes (abstract). Presented at the II International Congress on Psychogeriatric Medicine, Umeå, Sweden, Aug 28-31, 1985, abstract 128 [G]
41. Miller PS, Richardson JS, Jyu CA, Lemay JS, Hiscock M, Keegan DL: Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients. Am J Psychiatry 1988; 145:342-345 [A]
42. Trzepacz P, Baker R, Greenhouse J: A symptom rating scale for delirium. Psychiatry Res 1988; 23:89-97 [C]
43. Breitbart W, Rosenfeld B, Roth F, Smith MJ, Cohen K, Passik S: The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13:128-137 [C]
44. Engel G, Romano J: Delirium, a syndrome of cerebral insufficiency. J Chronic Dis 1959; 9:260-277 [G]
45. Pro J, Wells C: The use of the electroencephalogram in the diagnosis of delirium. Dis Nerv Syst 1977; 38:804-808 [D]
46. Tsai L, Tsuang MT: The Mini-Mental State test and computerized tomography. Am J Psychiatry 1979; 136:436-439 [C]
47. Hemmingsen R, Vorstrup S, Clemmesen L, Holm S, Tfelt-Hansen P, Sørensen AS, Hansen C, Sommer W, Bolwig TG: Cerebral blood flow during delirium tremens and related clinical states studied with xenon-133 inhalation tomography. Am J Psychiatry 1988; 145:1384-1390 [C]
48. Golinger RC, Peet T, Tune LE: Association of elevated plasma anticholinergic activity with delirium in surgical patients. Am J Psychiatry 1987; 144:1218-1220 [C]
49. Trzepacz PT, Wise MG: Neuropsychiatric aspects of delirium, in American Psychiatric Press Textbook of Neuropsychiatry. Edited by Yudofsky SC, Hales RE. Washington, DC, American Psychiatric Press, 1997, pp 447-470 [G]
50. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationships with baseline vulnerability. JAMA 1996; 275:852-857 [C]
51. American Psychiatric Association: Seclusion and Restraint: Psychiatric Uses. Washington, DC, APA, 1984, addendum 1992 [G]
52. Joint Commission on Accreditation of Healthcare Organizations: 1998 Accreditation Manual for Hospitals. Oak Brook Terrace, III, JCAHO, 1998 [G]
53. Inouye SK, Viscoli CM, Horwitz RI: A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119:474-481 [C]
54. Hashimoto H, Yamashiro M: Postoperative delirium and abnormal behaviour related with preoperative quality of life in elderly patients. Nippon Ronen Igakkai Zasshi 1994; 31:633-638 [C]
55. Lazarus HR, Hagens JH: Prevention of psychosis following open-heart surgery. Am J Psychiatry 1968; 124:1190-1195 [B]
56. Budd S, Brown W: Effect of a reorientation technique on post-cardiotomy delirium. Nurs Res 1974; 23:341-348 [B]
57. Williams MA, Campbell EB, Raynor WJ, Mlynarczyk SM, Ward SE: Reducing acute confusional states in elderly patients with hip fractures. Res Nurs Health 1985; 8:329-337 [B]
58. Cole MG, Primeau FJ, Bailey RF, Bonnycastle MJ, Masciarelli F, Engelsmann F, Pepin MJ, Ducic D: Systematic intervention for elderly inpatients with delirium: a randomized trial. Can Med Assoc J 1994; 151:965-970 [A]
59. Meagher DJ, O'Hanlon D, O'Mahony E, Casey PR: The use of environmental strategies and psychotropic medication in the management of delirium. BrJ Psychiatry 1996; 168:512-515 [C]
60. Allen JG, Lewis L, Blum S, Voorhees S, Jernigan S, Peebles MJ: Informing psychiatric patients and their families about neuropsychological assessment findings. Bull Menninger Clin 1986; 50:64-74 [G]
61. Sipahimalani A, Masand PS: Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997; 9:105-107 [G]
62. Ravona-Springer R, Dolberg OT, Hirschmann S, Grunhaus L: Delirium in elderly patients treated with risperidone: a report of three cases (letter). J Clin Psychopharmacol 1998; 18:171-172 [G]
63. Adams F, Fernandez F, Andersson BS: Emergency pharmacotherapy of delirium in the critically ill cancer patient. Psychosomatics 1986; 27(suppl 1):33-38 [F]
64. Muskin P, Mellman L, Kornfeld D: A "new" drug for treating agitation and psychosis in the general hospital: chlorpromazine. Gen Hosp Psychiatry 1986; 8:404-410 [D]
65. Rosen H: Double-blind comparison of haloperidol and thioridazine in geriatric patients. J Clin Psychiatry 1979; 40:17-20 [A]
66. Smith G, Taylor C, Linkous P: Haloperidol versus thioridazine for the treatment of psychogeriatric patients: a double-blind clinical trial. Psychosomatics 1974; 15:134-138 [A]
67. Tsuang MM, Lu LM, Stotsky BA, Cole JO: Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study. J Am Geriatr Soc 1971; 19:593-600 [A]
68. Kirven LE, Montero EF: Comparison of thioridazine and diazepam in the control of nonpsychotic symptoms associated with senility: double-blind study. J Am Geriatr Soc 1973; 12: 546-551 [A]
69. Thomas H, Schwartz E, Petrilli R: Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med 1992; 21:407-413 [A]
70. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobsen P: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153:231-237 [A]
71. van Leeuwen A, Molders J, Sterkmans P, Mielants P, Martens C, Toussaint C, Hovent A, Desseilles M, Koch H, Devroye A, Parent M: Droperidol in acutely agitated patients. J Nerv Ment Dis 1977; 164:280-283 [B]
72. Resnick M, Burton B: Droperidol vs haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry 1984; 45:298-299 [A]
73. Chen B, Cardasis W: Delirium induced by lithium and risperi-done combination (letter). Am J Psychiatry 1996; 153:1233-1234 [D]
74. Sipahimalani A, Sime RM, Masand PS: Treatment of delirium with risperidone. Int J Geriatric Psychopharmacology 1997; 1: 24-26 [G]
75. Frye MA, Coudreaut MF, Hakeman SM, Shah BG, Strouse TB, Skotzko CE: Continuous droperidol infusion for management of agitated delirium in an intensive care unit. Psychosomatics 1995; 36:301-305 [G]
76. Menza MA, Murray GB, Holmes VF, Rafuls WA: Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280 [B]
77. Wilt JL, Minnema AM, Johnson RF, Rosenblum AM: Torsade de pointes associated with the use of intravenous haloperidol. Ann Intern Med 1993; 119:391-394 [G]
78. Sharma ND, Rosman HS, Padhi D, Tisdale JE: Torsades de pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81:238-240 [G]
79. Jackson T, Ditmanson L, Phibbs B: Torsades de pointes and low-dose oral haloperidol. Arch Intern Med 1997; 157:2013-2015 [G]
80. Tesar GE, Murray GB, Cassem NH: Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985; 5:344-347 [G]
81. Liptzin B: Delirium, in Comprehensive Review of Geriatric Psychiatry, 2nd ed. Edited by Sadavoy J, Lazarus LW, Jarvik LF, Grossberg GT. Washington, DC, American Psychiatric Press, 1996, pp 479-495 [G]
82. Stern TA: The management of depression and anxiety following myocardial infarction. Mt Sinai J Med 1985; 52:623-633 [G]
83. Levenson JL: High-dose intravenous haloperidol for agitated delirium following lung transplantation. Psychosomatics 1995; 36:66-68 [G]
84. Riker RR, Fraser GL, Cox PM: Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994; 22:433-439 [D]
85. Metzger E, Friedman R: Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol 1993; 13:128-132 [G]
86. Hunt N, Stern TA: The association between intravenous haloperidol and torsades de pointes: three cases and a literature review. Psychosomatics 1995; 36:541-549 [F, G]
87. Lawrence KR, Nasraway SA: Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy 1997; 17:531-537 [F]
88. Menza MA, Murray GB, Holmes VF: Controlled study of extra-pyramidal reactions in the management of delirious medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung 1988; 17:238-241 [B]
89. Marcantonio ER, Goldman L, Mangione CM, Ludwig LE, Muraca B, Haslauer CM, Donaldson MC, Whittemore AD, Sugarbaker DJ, Poss R, Haas S, Cook EF, Orav EJ, Lee TH: A clinical prediction rule for delirium after elective noncardiac surgery. JAMA 1994; 271:134-139 [C]
90. Coffey B, Shader RI, Greenblatt DJ: Pharmacokinetics of benzodiazepines and psychostimulants in children. J Clin Psychopharmacol 1983; 3:217-225 [F]
91. Reiter S, Kutcher SP: Disinhibition and anger outbursts in adolescents treated with clonazepam (letter). J Clin Psychopharmacol 1991; 11:268 [G]
92. Greene LT: Physostigmine treatment of anticholinergic-drug depression in postoperative patients. Anesth Analg 1971; 50: 222-226 [C]
93. Goff DC, Garber HJ, Jenike MA: Partial resolution of ranitidine-associated delirium with physostigmine: case report. J Clin Psychiatry 1985; 46:400-401 [G]
94. Delberghe X, Zegers de Beyl D: Repeated delirium from homatropine eyedrops. Clin Neurol Neurosurg 1987; 89:53-54 [G]
95. Stern TA: Continuous infusion of physostigmine in anticholinergic delirium: case report. J Clin Psychiatry 1983; 44:463-464 [G]
96. Eisendrath SJ, Goldman B, Douglas J, Dimatteo L, Van Dyke C: Meperidine-induced delirium. Am J Psychiatry 1987; 144: 1062-1065 [D]
97. Mendelson G: Pheniramine aminosalicylate overdosage: reversal of delirium and choreiform movements with tacrine treatment. Arch Neurol 1977; 34:313 [G]
98. Physicians Desk Reference, 52nd ed. Montvale, NJ, Medical Economics Co, 1998 [G]
99. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW: Hepatoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271:992-998 [A]
100. Waterlot Y, Sabot JP, Marchal M, Vanherweghem JL: Pellagra: unusual cause of paranoid delirium in dialysis. Nephrol Dial Transplant 1986; 1:204-205 [G]
101. Bahr M, Sommer N, Petersen D, Wietholter H, Dichgans J: Central pontine myelinolysis associated with low potassium levels in alcoholism. J Neurol 1990; 237:275-276 [G]
102. O'Keeffe ST, Tormey WP, Glasgow R, Lavan JN: Thiamine deficiency in hospitalized elderly patients. Gerontology 1994; 40: 18-24 [G]
103. Day JJ, Bayer AJ, McMahon M, Pathy MS, Spragg BP, Rolands DC: Thiamine status, vitamin supplements and postoperative confusion. Age Ageing 1988; 17:29-34 [A]
104. Shapiro BA, Warren J, Egol AB, Greenbaum DM, Jacobi J, Nasraway SA, Schein RM, Spevetz A, Stone JR: Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Society of Critical Care Medicine. Crit Care Med 1995; 23:1596-1600 [F]
105. Stromgren LS: ECT in acute delirium and related clinical states. Convuls Ther 1997; 13:10-17 [G]
106. Kramp P, Bolwig TG: Electroconvulsive therapy in acute delirious states. Compr Psychiatry 1981; 22:368-371 [G]
107. Krystal AD, Coffey CE: Neuropsychiatric considerations in the use of electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 1997; 9:283-292 [G]
108. Fink M: Convulsive therapy in delusional disorders. Psychiatr Clin North Am 1995; 18:393-406 [F]
109. Dudley WHC, Williams JG: Electroconvulsive therapy in delirium tremens. Compr Psychiatry 1972; 13:357-360 [F]
110. Zwil AS, Pelchat RJ: ECT in the treatment of patients with neurological and somatic disease. Int J Psychiatry Med 1994; 24:1-29 [F]
111. Roberts AH: The value of ECT in delirium. Br J Psychiatry 1963; 109:653-655 [G]
112. Davis JM, Janicak PJ, Sakkar P, Gilmore C, Wang Z: Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convuls Ther 1991; 7:111-120 [E]
113. Shefner WA, Shulman RB: Treatment choice in neuroleptic malignant syndrome. Convuls Ther 1998; 8:267-279 [F, G]
114. Silverman M: Organic stupor subsequent to severe head injury treated with ECT. Br J Psychiatry 1964; 110:648-650 [G]
115. Kant R, Bogyi A, Carasella N, Fishman E, Kane V, Coffey E: ECT as a therapeutic option in severe brain injury. Convuls Ther 1995; 11:45-50 [G]
116. Burke WJ, Rubin EH, Zorumski CP, Wetzel RD: The safety of ECT in geriatric psychiatry. J Am Geriatr Soc 1987; 35:516-521 [B]
117. Calev A, Gaudino EA, Squires NK, Zervas IM, Fink M: ECT and non-memory cognition: a review. Br J Clin Psychol 1995; 34:505-515 [F]
118. Devanand DP, Fitzsimons L, Prudic J, Sackeim HA: Subjective side effects during electroconvulsive therapy. Convuls Ther 1995; 11:232-240 [A]
119. Fink M: Post-ECT delirium. Convuls Ther 1993; 9:326-330 [F]
120. Nelson JP, Rosenberg DR: ECT treatment of demented elderly patients with major depression: a retrospective study of efficacy and safety. Convuls Ther 1991; 7:157-165 [D]
121. Martin M, Figiel G, Mattingly G, Zorumski CF, Jarvis MR: ECT-induced interictal delirium in patients with a history of a CVA. J Geriatr Psychiatry Neurol 1992; 5:149-155 [B]
122. Figiel GS, Coffey CE, Djang WT, Hoffman G Jr, Doraiswamy PM: Brain magnetic resonance imaging findings in ECT-in-duced delirium. J Neuropsychiatry Clin Neurosci 1990; 2:53-58 [G]
123. Figiel GS, Krishnan KR, Doraiswamy PM: Subcortical structural changes in ECT-induced delirium. J Geriatr Psychiatry Neurol 1990; 3:172-176 [G]
124. Figiel GS, Hassen MA, Zorumski C, Krishnan KR, Doraiswamy PM, Jarvis MR, Smith DS: ECT-induced delirium in depressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 1991; 3:405-411 [G]
125. Zervas IM, Fink M: ECT and delirium in Parkinson's disease (letter). Am J Psychiatry 1992; 149:1758 [G]
126. Parry JW: In defense of lawyers. Hosp Community Psychiatry 1988; 39:1108-1109 [G]
127. Grossberg GT, Zimny GH: Medical-legal issues, in Comprehensive Review of Geriatric Psychiatry, 2nd ed. Edited by Sadavoy J, Lazarus LW, Jarvik LF, Grossberg GT. Washington, DC, American Psychiatric Press, 1996, pp 1037-1049 [G]
128. Goldstein R: Non compos mentis: the psychiatrist's role in guardianship and conservatorship proceedings involving the elderly, in Geriatric Psychiatry and the Law. Edited by Rosner R, Schwartz HI. New York, Plenum, 1987, pp 269-278 [G]
129. Fogel B, Mills M, Landen J: Legal aspects of the treatment of delirium. Hosp Community Psychiatry 1986; 37:154-158 [F]
130. Breitbart W, Marotta RF, Call P: AIDS and neuroleptic malignant syndrome. Lancet 1988; 2:1488-1489 [D]
131. Hriso E, Kuhn T, Masdeu JC, Grundman M: Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatry 1991; 148:1558-1561 [D]
132. Someya T, Shibasaki M, Noguchi T, Takahashi S, Inaba T: Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbamyl reduction. J Clin Psychopharmacol 1992; 12:169-174 [B]
133. Tune L, Carr S, Hoag E, Cooper T: Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 1992; 149: 1393-1394 [G]
134. Tune L, Carr S, Cooper T: Association of anticholinergic activity of prescribed medications with postoperative delirium. J Neuropsychiatry Clin Neurosci 1993; 5:208-210 [C]
135. Tune LE, Damlouji NF, Holland A, Gardner TJ, Folstein MF, Coyle JT: Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981; 2:651-653 [C]